BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation

Who May Qualify: - Men and women ages 18-85 years with history of documented paroxysmal (\<7 days) atrial fibrillation - AF Burden (% time in AF) of more than 0.5% and less than 25% as evident by a continuous 14 days ECG recording at baseline (at minimum 168 hours) - Ability and willingness to sign an willing to sign a consent form form - Ability and willingness to use CardiaCare home care device and ECG chest patch and has an available smart phone - Known symptomatic AF event over the recent 3 months - Willing not to change the antiarrhythmic treatment Who Should NOT Join This Trial: - Hemodynamic instability (systolic blood pressure \<100mmHg or heart rate\>170 bpm at Baseline) during recruitment visit - Known history or current diagnosis of atrial flutter - An active myocardial infarction evident from ECG - Recent stroke or myocardial infarction (\<6 months) - History of sick sinus syndrome 2nd or 3rd degree AV block, bifascicular block or prolonged (PR\>300ms) 1st degree AV block - Unilateral or bilateral vagotomy - History of persistent AF with documented AF episodes of \>7 days - Significant valvular disorder (i.e., prosthetic valve or hemodynamically relevant valvular diseases or valvular AF) - History of Impaired systolic function with EF\<40 % or NY Class III or IV heart failure classification - Dilatated left atria with a diameter \> 50mm as evident by an echocardiogram - Currently enrolled in another study - Recurrent vaso-vagal syncopal episodes - Pregnancy or breast feeding - Pacemaker or CRTD or any implanted electrical stimulating device - History of epilepsy or seizures - Peripheral neuropathy or dermatological condition affecting the tested upper extremity area - Unsuitable for participating in the study according to attending physician Always talk to your doctor about whether this trial is right for you.